ArticleCancers2021

Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.

Hsin-Pai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.